Skip to content
Screener

Viridian Therapeutics, Inc. VRDN Prepaid & Other Current

Prepaid & Other Current at other companies

Amgen logo
AmgenAMGN
$4.53B+32.2%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$42.76M-16.4%
Vera Therapeutics logo
Vera TherapeuticsVERA
$19.04M+17.2%
PVL
Palvella TherapeuticsPVLA
$1.38M-24.9%
Regenxbio logo
RegenxbioRGNX
$11.9M+10.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$4.79M+10.2%

Other financials

Income statement

See full
Revenue$284.0K+279%
Operating income-$126.3M-18.3%
Net income-$127.1M-26.2%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$165.0M+40.6%
Total debt$114.4M+395%
Total equity$662.1M+28.5%
Total assets$1.1B+88.4%

Cash flow

See full
Operating cash flow-$105.3M-39.7%
CapEx$1.3M+3,010%
Free cash flow-$106.6M-41.4%

Valuation

See full
Market cap$2.67B+93.8%
Enterprise value$2.62B+104%
P/S37.6×-4,484×

Profitability

See full
Gross margin36.3%
Operating margin-569.7%-284pp
Net margin-544.1%-271pp
FCF margin-471%-235pp

Returns & leverage

See full
Return on equity-65.7%-0.1pp
Debt / equity0.2×+0.1×
Current ratio16.9×+5.9×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:31 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001590750-26-000018

FAQ

What is Viridian Therapeutics, Inc.'s prepaid & other current?
Viridian Therapeutics, Inc. (VRDN) reported prepaid & other current of $24.74M in Q2 2026.
How has Viridian Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Viridian Therapeutics, Inc.'s prepaid & other current increased by 60.7% year-over-year, from $15.39M to $24.74M.
What is the long-term trend for Viridian Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s prepaid & other current has grown at a 58.3% compound annual growth rate (CAGR), from $1.97M to $19.58M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Viridian Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude